CALABRESE, LAURA
 Distribuzione geografica
Continente #
AS - Asia 81
NA - Nord America 63
EU - Europa 17
Continente sconosciuto - Info sul continente non disponibili 6
SA - Sud America 5
AF - Africa 1
Totale 173
Nazione #
US - Stati Uniti d'America 59
VN - Vietnam 29
SG - Singapore 19
IT - Italia 13
CN - Cina 9
JP - Giappone 6
HK - Hong Kong 5
CA - Canada 3
KR - Corea 3
PH - Filippine 3
AR - Argentina 2
BR - Brasile 2
DE - Germania 2
BD - Bangladesh 1
BG - Bulgaria 1
ES - Italia 1
JO - Giordania 1
MX - Messico 1
NP - Nepal 1
TH - Thailandia 1
TR - Turchia 1
TW - Taiwan 1
UZ - Uzbekistan 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 167
Città #
San Jose 28
Council Bluffs 11
Ho Chi Minh City 9
Singapore 7
Tokyo 5
Ashburn 4
Hong Kong 4
Rome 4
Beijing 3
Bologna 3
Frankfurt am Main 2
Haiphong 2
Hanoi 2
Quận Ba 2
Santa Clara 2
São Paulo 2
Altinordu 1
Amman 1
Ascoli Piceno 1
Athens 1
Bacolod City 1
Bari 1
Buffalo 1
Can Tho 1
Eutawville 1
Floral Park 1
Florence 1
Gangseo-gu 1
Grand Falls-Windsor 1
Gumi 1
Gwanak-gu 1
Hamilton 1
Huizhou 1
Huntington Park 1
Ishwardi 1
Jhāpā Bajār 1
Kaohsiung 1
Kingston 1
Krugersdorp 1
Long Xuyen 1
Louisville 1
Madrid 1
Manila 1
Maracaibo 1
Matino 1
Milan 1
Morelia 1
New Philadelphia 1
New York 1
Nha Trang 1
North Bay 1
Osaka 1
Phra Nakhon Si Ayutthaya 1
Plant City 1
San Clemente del Tuyú 1
Sofia 1
Suzhou 1
Tandag 1
Tashkent 1
Toms River 1
Virginia Beach 1
Vĩnh Yên 1
Xinxiang 1
Zárate 1
Totale 138
Nome #
Clinical course of atopic dermatitis after dupilumab discontinuation: a multicentre real-world study 38
Letter: Optimizing Dupilumab Dosing in Atopic Dermatitis: Real-World Evidence 37
Therapeutic outcomes across Janus kinase inhibitors in prurigo nodularis 36
Psoriasis and Seronegative Spondyloarthropathy in Atopic Dermatitis Patients Treated with Dupilumab or Tralokinumab: A Multicentre Observational Study 32
Safety and Effectiveness of Dupilumab in Atopic Dermatitis Patients with Hematologic Comorbidities: A Multicenter, Retrospective Study 26
Dupilumab for prurigo nodularis: real-world outcomes up to 104 weeks from the Dupilumab Italian Prurigo Nodularis (DUPItaPN) study 4
Totale 173
Categoria #
all - tutte 752
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 752


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2025/2026136 0 0 0 0 0 0 5 46 49 22 9 5
2026/202737 20 16 1 0 0 0 0 0 0 0 0 0
Totale 173